Y33* (p.Tyr33Ter) variant of ACVR1 (Activin receptor type-1)

Y33* (p.Tyr33Ter) in ACVR1 (Activin receptor type-1) is a protein-truncating change. Clinical records from EBI and UniProt describe it as benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.41 / 1. The record also includes population frequency data and structural context.

Y33* (p.Tyr33Ter) variant details